期刊论文详细信息
BMC Cancer | |
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol | |
Shaojun Zhu1  Jeremie Calais2  Johannes Czernin2  Matthias Eiber3  Ken Herrmann4  Wolfgang P. Fendler4  Nader Hirmas4  Martin Stuschke5  Boris Hadaschik6  David Elashoff7  Nicholas G. Nickols8  Amar U. Kishan9  | |
[1] Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California, Peter Norton Medical Building, 200 Medical Plaza, Suite B-114-51, 90095-7370, Los Angeles, CA, USA;Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California, Peter Norton Medical Building, 200 Medical Plaza, Suite B-114-51, 90095-7370, Los Angeles, CA, USA;Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA;Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA;Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45131, Essen, Germany;Department of Radiotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;Department of Urology, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany;Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA;Department of Medicine Statistics Core (DOMStat), UCLA CTSI Biostatistics and Computational Biology, University of California, Los Angeles, USA;Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA;Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA;Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA;Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA;Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA;Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA;Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA; | |
关键词: Prostate cancer; PSMA; PET/CT; Randomized phase 3 trial; Definitive radiation therapy; | |
DOI : 10.1186/s12885-021-08026-w | |
来源: Springer | |